A solid phase chemiluminescent immunoassay (LIA) for testosterone glicuronide in diluted urines.
A chemiluminescent immunoassay (LIA) method in solid phase for the measurement of testosterone 17 beta-D-glicuronide (TG) in diluted urine is described, which utilizes as tracer a TG-isoluminol conjugate (TG-ABEI). An IgG fraction of antiserum of TG-BSA, has been passively adsorbed to the walls of polystyrene tubes. After the binding reaction the coated tubes were washed with buffer and the measure of chemiluminescence reaction was performed at high pH. The assay was validated in terms of specificity, accuracy, sensitivity and precision. The values obtained by chemiluminescence immunoassay were compared with that obtained by the RIA method, and the two methods agreed well (r = 0.95, n = 28). The assay method offers the advantage of speed and does not involve the use of radioisotopes or of a centrifugation step. Preliminary results show that the mean 24 h urinary TG excretion in a group of hirsute women is higher than in the control group, and decreases after suppression with dexamethasone for 1 month of therapy.
D003480:Cushing Syndrome / Q000652:urine; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006628:Hirsutism / Q000652:urine; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007074:Immunoglobulin G; D008163:Luminescent Measurements; D013739:Testosterone / Q000031:analogs & derivatives* / Q000652:urine
D007074:Immunoglobulin G; C015529:testosterone glucuronate; D013739:Testosterone